Sarepta Therapeutics, Inc.
) was a big mover last session, as its shares rose over 40% on the
day. The move came on solid volume too with far more shares
changing hands than in a normal session. This continues the uptrend
for the company since Jan 7, as the stock is now up almost 57%.
In the last 30-day frame, the company did not witness any estimate
revision and the Zacks Consensus Estimate hasn't been in a trend
either. Yesterday's price action is encouraging though, so make
sure to keep a close watch on this firm in the near future.
Sarepta currently has a Zacks Rank #3 (Hold) while its
Other better-ranked stocks in the medical sector include
Emergent BioSolutions, Inc.
). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research?
Today, you can download
7 Best Stocks for the Next 30 Days
Click to get this free report >>
ACTELION LTD (ALIOF): Get Free Report
EMERGENT BIOSOL (EBS): Free Stock Analysis
GENTIUM SPA-ADR (GENT): Free Stock Analysis
SAREPTA THERAP (SRPT): Free Stock Analysis
To read this article on Zacks.com click here.